Created at Source Raw Value Validated value
May 3, 2021, 10:09 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Infliximab+ Standard Treatment+ Colchicine\u061b Patients in this group were treated concomitantly with 1 mg of colchicine (for 7 days) with infliximab (single dose of 300 mg on the first day of treatment) and recommended treatments for COIVD-19 (standard treatment provided in the latest national guideline to COVID-19 disease).Currently the standard national guideline includes: 200 mg hydroxychloroquine or 250 mg chloroquine (two tablets every 12 hours on the first day and one tablet every 12 hours for at least 7 days and up to 14 days) + kaletra (lupinavir / ritonavir) 200/50 mg every 12 hours 2 tablets for a minimum of 7 days and a maximum of 14 days or tablets (Atazanavir / Ritonavir) 300/100 mg/day with food for a minimum of 7 days and a maximum of 14 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Infliximab+ Standard Treatment\u061b In addition to standard treatment, patients in this group will receive infliximab (single dose of 300 mg on the first day).Currently the standard national guideline includes: 200 mg hydroxychloroquine or 250 mg chloroquine (two tablets every 12 hours on the first day and one tablet every 12 hours for at least 7 days and up to 14 days) + kaletra (lupinavir / ritonavir) 200/50 mg every 12 hours 2 tablets for a minimum of 7 days and a maximum of 14 days or tablets (Atazanavir / Ritonavir) 300/100 mg/day with food for a minimum of 7 days and a maximum of 14 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1963, "treatment_name": "Colchicine+infliximab", "treatment_type": "Metabolic agents+other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 650, "treatment_name": "Infliximab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}]